John Stanford

speaker

1,479 appearances 11 recordings 1 series first heard May 2026 last heard 13 Aug

John Stanford’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 11 in all, peaking in Jul 2026 with 4.

Appearances

newest first · ▶ plays the moment

Making Medicine · The Relay Continues: Building Biotechs That Save Lives | How America Makes Medicine Ep. 3 · 6 Aug 2026 podcast

And I've had other investors come on saying with, but for the lower cost point, these three assets would have never moved forward.

There never would have been the capital to explore that space.

We had no idea this is where the conversation was going to go.

It's also very interesting that you had to pilot that, that no one had really explored that before.

I am just genuinely curious.

Is there a time window when you can still conduct these from passing to that?

Or can you really work with the decedent population a long time after death?

Well, it's interesting that you have not just innovated in the lab and moving a drug forward, but even the underlying logistics of the manufacturing to meet sort of the needs, not just of the U.S.

population, but also the global population.

I also think one of the points we're trying to make to listeners and policymakers is if

Even if you use a CRO or CDMO in China to move it forward, I think you're the perfect story of you've had this incredible success.

And from a monetary and resources standpoint, that success, generally speaking, is staying here in the U.S.

and you're choosing to reinvest it through the foundation, through M34, through others.

to move things forward.

And so, I mean, part of my view about like, oh, let's wall off China is, well, a lot of the upside that comes out of that or any other country ends up staying here in the form of people like you who then choose to redeploy it at some other challenge.

And when M34 is successful, you're going to just get to continue to grow that impact in the U.S.

Yeah, I will.

And I think that'll be the market goal.

plays an incredible role.

I want to switch gears a little bit to take advantage of the time we have you on, you know, part of this broader series is talking about the relay race of drug development.

Showing 241–260 of 1,479 · page 13 of 74